Scinai Immunotherapeutics (SCNI) Non-cash Items (2018 - 2021)
Scinai Immunotherapeutics (SCNI) posted Non-cash Items of $1.1 million for Q4 2021, down 30.96% sequentially from $1.6 million in Q3 2021, and down 60.03% YoY from $2.7 million in Q4 2020.
Scinai Immunotherapeutics (SCNI) Non-cash Items (2018 - 2021) Analysis & Trends
Scinai Immunotherapeutics has reported Non-cash Items for 4 years, with the latest figure at $1.1 million in Q4 2021.
- Quarterly Non-cash Items fell 60.03% year-over-year to $1.1 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $9.2 million (up 122.99% YoY) and the FY2021 annual result came in at $4.2 million, up 107.92% from the prior year.
- Non-cash Items declined to $1.1 million in Q4 2021 per SCNI's latest filing, from $1.6 million in the prior quarter.
- Over five years, Non-cash Items peaked at $29.5 million in Q2 2020 and troughed at -$70.0 million in Q3 2020.
- A 4-year average of -$3.3 million and a median of $1.1 million in 2021 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2019 and 2021: Non-cash Items plunged 317.66% in 2019, then jumped 102.25% in 2021.
- Over 4 years, Non-cash Items stood at $957000.0 in 2018, then slumped by 317.66% to -$2.1 million in 2019, then surged by 230.68% to $2.7 million in 2020, then slumped by 60.03% to $1.1 million in 2021.
- According to Business Quant data, Non-cash Items over the past three periods registered $1.1 million, $1.6 million, and $5.6 million for Q4 2021, Q3 2021, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.09 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 1.58 Mn |
| Sep 30, 2021 | 1.58 Mn |
| Jun 30, 2021 | 5.60 Mn |
| Jun 30, 2021 | 5.60 Mn |
| Mar 31, 2021 | 898,000.00 |
| Mar 31, 2021 | 898,000.00 |
| Dec 31, 2020 | 2.72 Mn |
| Dec 31, 2020 | 2.72 Mn |
| Sep 30, 2020 | -69.97 Mn |
| Sep 30, 2020 | -69.97 Mn |
| Jun 30, 2020 | 29.48 Mn |
| Jun 30, 2020 | 29.48 Mn |
| Mar 31, 2019 | -2.08 Mn |
| Mar 31, 2019 | -2.08 Mn |
| Mar 31, 2018 | 957,000.00 |
| Mar 31, 2018 | 957,000.00 |